Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BYMedicine

Association between the uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in U.S. adults with type 2 diabetes: A cross-sectional study of NHANES 2009 to 2018.

  1. 1Departments of Nephrology, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
  2. 2College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning, China.

Abstract

The uric-acid-to- high-density lipoprotein-cholesterol ratio (UHR) combines 2 circulating biomarkers related to metabolic and inflammatory processes. Its association with prevalent diabetic kidney disease (DKD) was examined in U.S. adults with type 2 diabetes mellitus. This study aimed to examine the cross-sectional association between UHR and prevalent DKD and assess its incremental discrimination beyond the specified covariate model. We analyzed 4010 adults with type 2 diabetes mellitus from NHANES 2009 to 2018 using the complex survey design. DKD was defined as urinary albumin-to-creatinine ratio ≥30 mg/g and/or estimated glomerular filtration rate <60 mL/min/1.73 m2, calculated using the 2009 chronic kidney disease epidemiology collaboration equation without its race coefficient. Strict DKD required both abnormalities; severe DKD required urinary albumin-to-creatinine ratio ≥300 mg/g. Model 3 was the primary confounder-adjusted model, and model 4 added laboratory indicators as an extended sensitivity analysis. Supplementary analyses assessed nonlinearity, discrimination and graphical calibration. Exploratory unweighted category-based net reclassification improvement used 500 bootstrap replicates and percentile confidence intervals. Of 4010 participants, 1576 had study-defined DKD; the weighted prevalence was 35.4%. In model 3, the highest versus lowest ln-UHR quartile had an odds ratio of 2.43 (95% confidence interval 1.75-3.38) for original DKD, 4.55 (2.81-7.35) for strict DKD and 2.82 (1.57-5.06) for severe DKD. Estimates were attenuated in model 4, with the severe-DKD contrast no longer meeting the 0.05 threshold. The laboratory-adjusted spline indicated nonlinearity (P < .001). In the separate laboratory-inclusive discrimination analysis, adding ln-UHR increased apparent area under the curve from 0.75 to 0.76; the unweighted net reclassification improvement was 1.9% (95% confidence interval 0.8%-3.1%). Higher UHR was associated with prevalent DKD after adjustment for the selected potential confounders. Supplementary analyses showed a small increase in apparent discrimination. These cross-sectional findings require prospective investigation and independent external validation before use for future risk prediction or clinical screening.

Related

  1. Association of the triglyceride-to-high-density lipoprotein cholesterol ratio with kidney stone status: cross-sectional and machine-learning analyses
    Hu Liang, Dekai Hu, Junzhi Zhang +4
    Renal failurePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Association between the cholesterol-high-density lipoprotein-glucose (CHG) index and albuminuria risk in diabetic patients
    Yuren Zhang, Jinting Xu, Yiping Zhang +2
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  3. Association between the cholesterol-high-density lipoprotein-glucose index and the incidence of new-onset diabetes in patients with chronic gastrointestinal diseases: A prospective cohort study.
    Liyan Lv, Juhua Wu, Xiaoqing Lin +2
    Journal of diabetes investigationPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismEurope PMC
  4. Nonlinear association of cholesterol, high-density lipoprotein, and glucose index with the risk of prediabetes and diabetes in normal-weight middle-aged and older Chinese adults: a multicenter retrospective cohort study
    Junling Ding, Zhimao Cai, Xianglin Wang +2
    Frontiers in nutritionPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMCEurope PMC
  5. Association between atherogenic index of plasma and microvascular complications in patients with type 2 diabetes achieving low-density lipoprotein cholesterol targets: a real-world cohort study.
    Shengchao Zhang, Yuzhao Shao, Min Li +7
    Journal of global healthPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
BibTeX
@article{tan2026association,
  title = {{Association between the uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in U.S. adults with type 2 diabetes: A cross-sectional study of NHANES 2009 to 2018.}},
  author = {Ruolan Tan and Wei Tan and Yulin Hu},
  journal = {Medicine},
  year = {2026},
  month = oct,
  doi = {10.1097/md.0000000000051033},
  url = {https://europepmc.org/article/MED/42888531},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Association between the uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in U.S. adults with type 2 diabetes: A cross-sectional study of NHANES 2009 to 2018.
AU  - Ruolan Tan
AU  - Wei Tan
AU  - Yulin Hu
PY  - 2026
DA  - 2026/10/01
JO  - Medicine
DO  - 10.1097/md.0000000000051033
UR  - https://europepmc.org/article/MED/42888531
AB  - The uric-acid-to- high-density lipoprotein-cholesterol ratio (UHR) combines 2 circulating biomarkers related to metabolic and inflammatory processes. Its association with prevalent diabetic kidney disease (DKD) was examined in U.S. adults with type 2 diabetes mellitus. This study aimed to examine the cross-sectional association between UHR and prevalent DKD and assess its incremental discrimination beyond the specified covariate model. We analyzed 4010 adults with type 2 diabetes mellitus from NHANES 2009 to 2018 using the complex survey design. DKD was defined as urinary albumin-to-creatinine ratio ≥30 mg/g and/or estimated glomerular filtration rate <60 mL/min/1.73 m2, calculated using the 2009 chronic kidney disease epidemiology collaboration equation without its race coefficient. Strict DKD required both abnormalities; severe DKD required urinary albumin-to-creatinine ratio ≥300 mg/g. Model 3 was the primary confounder-adjusted model, and model 4 added laboratory indicators as an extended sensitivity analysis. Supplementary analyses assessed nonlinearity, discrimination and graphical calibration. Exploratory unweighted category-based net reclassification improvement used 500 bootstrap replicates and percentile confidence intervals. Of 4010 participants, 1576 had study-defined DKD; the weighted prevalence was 35.4%. In model 3, the highest versus lowest ln-UHR quartile had an odds ratio of 2.43 (95% confidence interval 1.75-3.38) for original DKD, 4.55 (2.81-7.35) for strict DKD and 2.82 (1.57-5.06) for severe DKD. Estimates were attenuated in model 4, with the severe-DKD contrast no longer meeting the 0.05 threshold. The laboratory-adjusted spline indicated nonlinearity (P < .001). In the separate laboratory-inclusive discrimination analysis, adding ln-UHR increased apparent area under the curve from 0.75 to 0.76; the unweighted net reclassification improvement was 1.9% (95% confidence interval 0.8%-3.1%). Higher UHR was associated with prevalent DKD after adjustment for the selected potential confounders. Supplementary analyses showed a small increase in apparent discrimination. These cross-sectional findings require prospective investigation and independent external validation before use for future risk prediction or clinical screening.
SN  - 0304-5412
SN  - 1536-5964
ER  -